Pulmonary Toxicity Associated with Gemcitabine
Abstract
No abstrat available.
Image: Yale School of Medicine Historical Library, Yale University. New Haven, CT, USA.
Downloads
References
Lorusso D, Ferrandina G, Fruscella E, Marini L, Adamo V, Scambia G. Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives. Int J Gynecol Cancer 2005; 15:1002-13. [PMID 16343176] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/118663642/HTMLSTART)
Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80:286-91. [PMID 9217042] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/75502650/HTMLSTART)
Gupta N, Ahmed I, Steinberg H, Patel D, Nissel-Horowitz S, Mehrotra B. Gemcitabine-induced pulmonary toxicity: case report and review of the literature. Am J Clin Oncol 2002; 25:96-100. [PMID 11823707] (FULL TEXT: http://journals.lww.com/amjclinicaloncology/pages/articleviewer.aspx?year=2002&issue=02000&article=00021&type=abstract)
Linskens RK, Golding RP, van Groeningen CJ, Giaccone G. Severe acute lung injury induced by gemcitabine. Neth J Med 2000; 56:232-5. [PMID 10821980]
Marruchella A, Fiorenzano G, Merizzi A, Rossi G, Chiodera PL. Diffuse alveolar damage in a patient treated with gemcitabine. Eur Respir J 1998; 11:504-6. [PMID 9551762] (FULL TEXT: http://erj.ersjournals.com/cgi/reprint/11/2/504)
Rosado MF, Kett DH, Schein RM, Baraona FJ, Sridhar KS. Severe pulmonary toxicity in a patient treated with gemcitabine. Am J Clin Oncol 2002; 25:31-3. [PMID 11823691] (FULL TEXT: http://journals.lww.com/amjclinicaloncology/pages/articleviewer.aspx?year=2002&issue=02000&article=00005&type=abstract)
Roychowdhury DF, Cassidy CA, Peterson P, Arning M. A report on serious pulmonary toxicity associated with gemcitabine-based therapy. Invest New Drugs 2002; 20:311-5. [PMID 12201493] (FULL TEXT: http://www.springerlink.com/content/1ldp62up20rf6xqf/fulltext.pdf)
Barlési F, Villani P, Doddoli C, Gimenez C, Kleisbauer JP. Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol 2004;18:85-91. [PMID 14748759] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/118782738/HTMLSTART)
Boiselle PM, Morrin MM, Huberman MS. Gemcitabine pulmonary toxicity: CT features. J Comput Assist Tomogr 2000; 24:977-80. [PMID 11105721] (FULL TEXT: http://journals.lww.com/jcat/pages/articleviewer.aspx?year=2000&issue=11000&article=00027&type=abstract)
Shaib W, Lansigan F, Cornfeld D, Syrigos K, Saif MW. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. JOP. J Pancreas (Online) 2008; 9:708-14. [PMID 1898155] (FULL TEXT: http://www.joplink.net/prev/200811/07.html)
Hiraya D, Kagohashi K, Sakamoto N, Kondo T, Satoh H. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer. JOP. J Pancreas (Online) 2010; 11:186-8. (FULL TEXT: http://www.joplink.net/prev/201003/01.html)
Sauer-Heilborn A, Kath R, Schneider CP, Höffken K. Severe non-haematological toxicity after treatment with gemcitabine. J Cancer Res Clin Oncol 1999; 125:637-40. [PMID 10541971] (FULL TEXT: http://www.springerlink.com/content/3n28h01ma3dek2cn/fulltext.pdf)
Copyright (c) 2010 Muhammad Wasif Saif
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.